KevinMD January 16, 2024
Yongjia Wang

In 2020, the ICPerMed (International Consortium for Personalized Medicine) published a ten-year vision for how personalized medicine, a new form of medicine, has the potential to rebuild an equitable and accessible health care system by 2030.

Precision or personalized medicines are drugs developed with genomic sequencing technologies, targeting the critical genes in specific types of cancer or genetic diseases. Thus, PMs are highly effective in treating their targeted patients, sometimes buying patients years compared to other standard treatments.

Since the Human Genome Project’s (HGP) release of the human genome sequence in 2003 and President Obama’s 216 million dollar PM initiative in 2016, more and more scientists and pharmaceutical companies are focusing on this new field.

As a pre-med student who...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article